JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shu-Hang, N.
Right arrow Articles by Tzu-Chen, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shu-Hang, N.
Right arrow Articles by Tzu-Chen, Y.

Clinical Usefulness of 18F-FDG PET in Nasopharyngeal Carcinoma Patients with Questionable MRI Findings for Recurrence

Ng Shu-Hang, MD1, Joseph Chang Tung-Chieh, MD, MSc2, Chan Sheng-Chieh, MD3, Ko Sheung-Fat, MD1, Wang Hung-Ming, MD4, Liao Chun-Ta, MD5, Chang Yu-Chen, MD3, Wuu-Jyh Lin, PhD6, Fu Ying-Kai, PhD6 and Yen Tzu-Chen, MD, PhD3

1 Department of Diagnostic Radiology, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan
2 Department of Radiation Oncology, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan
3 Department of Nuclear Medicine, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan
4 Department of Medical Oncology, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan
5 Department of Otorhinolaryngology, Chang Gung Memorial Hospital Linkou Medical Center, Taoyuan, Taiwan
6 Institute of Nuclear Energy Research, Taoyuan, Taiwan



View larger version (90K):

[in a new window]
 
FIGURE 1. A 53-y-old man with NPC 14 mo after intensity-modulated radiation therapy and intracavity brachytherapy. (A) Axial T1-weighted MR image shows an irregular mass (arrow) in the left nasopharynx. (B) 18F-FDG PET image shows a false-positive finding. Histopathologic findings showed acute and chronic inflammation, and follow-up MRI 4 mo later showed regression of the lesion.

 


View larger version (85K):

[in a new window]
 
FIGURE 2. A 59-y-old man with NPC 16 mo after concurrent chemoradiation therapy. (A) Axial T2-weighted MR image shows an irregular mass (arrow) in the left nasopharynx. (B) 18F-FDG PET finding is true negative, with the image showing no uptake in the corresponding area. Subsequent biopsy showed this was an inflammatory mass.

 


View larger version (67K):

[in a new window]
 
FIGURE 3. A 44-y-old woman with NPC 9 mo after intensity-modulated radiation therapy. (A) Coronal contrast-enhanced T1-weighted MR image shows an asymmetric mucosal thickening (arrow) in the left nasopharynx. (B) However, the negative 18F-FDG PET findings are false, for histopathologic examination showed a recurrent NPC.

 


View larger version (75K):

[in a new window]
 
FIGURE 4. A 45-y-old woman with NPC 12 mo after intensity-modulated radiation therapy. (A) Axial T2-weighted MR image shows a questionable left-sided high jugular adenopathy (arrow). (B) 18F-FDG PET scan reveals an additional metastatic node (arrow) in the right supraclavicular fossa in addition to the left-sided high jugular metastatic node.

 


View larger version (82K):

[in a new window]
 
FIGURE 5. A 45-y-old woman with NPC 12 mo after concurrent chemoradiation therapy. (A) 18F-FDG PET scan shows an area of uptake (arrow) in the left hilar region. (B) Chest CT scan shows a small pulmonary nodule (arrow, top) in the left upper lobe and discloses another tiny nodule (arrow, bottom) in the right lower lobe. A follow-up CT scan 2 mo later showed definite enlargement at these 2 lung nodules, consistent with lung metastases.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.